20 Best Dividend Growth Stocks with High Yields

17. AbbVie Inc. (NYSE:ABBV)

Dividend Yield as of May 13: 3.55%

AbbVie Inc. (NYSE:ABBV) is an American pharmaceutical company that is known for its focus on innovation and chronic disease treatments. The company is a strong dividend payer, having raised its payouts for 52 consecutive years. It offers a quarterly dividend of $1.64 per share and has a dividend yield of 3.55%, as of May 13.

AbbVie Inc. (NYSE:ABBV) delivered strong financial results in the first quarter of 2025. Revenue reached $13.3 billion, marking an 8.3% year-over-year increase and surpassing expectations by $422 million. Growth in its immunology portfolio, particularly from Skyrizi and Rinvoq, helped balance the anticipated decline in Humira sales. The company also saw solid performance in neuroscience and oncology, with Elahere generating $179 million globally, boosted by favorable results from the MIRASOL trial, which showed it significantly outperformed chemotherapy in ovarian cancer treatment.

AbbVie Inc. (NYSE:ABBV) continues to strengthen its pipeline through strategic acquisitions and partnerships. Recent moves include acquiring ImmunoGen to secure Elahere, purchasing Nimble Therapeutics to bolster its autoimmune offerings, and entering a licensing deal with Gubra to advance in the obesity drug market—a space dominated by rivals Eli Lilly and Novo Nordisk. ABBV has surged by over 5% since the start of 2025, which also makes it one of the best dividend stocks on our list.